Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The Promising Role of Artificial Intelligence in Navigating Lung Cancer Prognosis
3
Zitationen
6
Autoren
2024
Jahr
Abstract
Incorporating AI in lung cancer management is a disruptive innovation that has improved diagnosis accuracy, prognosis prediction and treatment modalities. In this literature review, we seek to identify the role of artificial intelligence (AI) and machine learning (ML) in lung cancer detection, diagnosis and treatment between 2010 and 2023. A total of 55 studies were selected systematically from databases such as IEEE Xplore, Scopus and PubMed via a PRISMA-based approach. The analysis reveals that artificial intelligence (AI) techniques, specifically convolutional neural networks (CNNs) and natural language processing (NLP), highly improve the precision of initial detection and imaging of lung cancer. Also, CNN distinguishes between benign and malignant nodules, thus aiding early diagnosis and reducing unnecessary biopsies. On the other hand, NLP is utilized to extract relevant clinical information from electronic health records and unstructured medical texts, thereby enhancing the understanding of patient histories and improving treatment planning. Sensitive and specific scores usually higher than standard techniques characterize these technologies. Results show that traditional statistical approaches couldn’t match AI models whose predictive accuracies are outstanding while providing better care to patients through personalised treatment plans. Furthermore, multi-omics data analysis for personalised treatment planning and clinical decision-making optimisation via Clinical Decision Support Systems (CDSS) powered by AI are some ways artificial intelligence has exhibited its potential in this area. Given this, future studies should aim to fine-tune AI algorithms, improve data integration, and address ethical issues promoting responsible use of AI technologies in clinical practice settings. Despite these advances, data quality, model interpretability, and integration into clinical workflows persist. This review demonstrates the demand for continued research and collaboration from different disciplines so that the complete possibilities of AI in fighting lung cancer may be realised.
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 28.943 Zit.
TNM Classification of Malignant Tumours
1987 · 16.123 Zit.
A survey on deep learning in medical image analysis
2017 · 13.625 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.776 Zit.
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
2010 · 9.111 Zit.